Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBIT Margin (2021 - 2025)

Tenon Medical (TNON) has 5 years of EBIT Margin data on record, last reported at 289.17% in Q3 2025.

  • For Q3 2025, EBIT Margin rose 7328.0% year-over-year to 289.17%; the TTM value through Sep 2025 reached 405.17%, up 913.0%, while the annual FY2024 figure was 420.08%, 11704.0% up from the prior year.
  • EBIT Margin reached 289.17% in Q3 2025 per TNON's latest filing, up from 506.56% in the prior quarter.
  • Across five years, EBIT Margin topped out at 289.17% in Q3 2025 and bottomed at 7331.82% in Q2 2021.
  • Average EBIT Margin over 5 years is 1751.17%, with a median of 581.7% recorded in 2023.
  • Peak YoY movement for EBIT Margin: tumbled -166817bps in 2022, then skyrocketed 345979bps in 2023.
  • A 5-year view of EBIT Margin shows it stood at 4833.96% in 2021, then soared by 41bps to 2862.09% in 2022, then surged by 86bps to 388.74% in 2023, then dropped by -6bps to 412.08% in 2024, then increased by 30bps to 289.17% in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT Margin were 289.17% in Q3 2025, 506.56% in Q2 2025, and 506.47% in Q1 2025.